RVMD ▲ +0.4% - Revolution Medicines, Inc. $RVMD PT raised to $275 at Needham Needham raised its price target for Revolution Medicines to $275, supporting a modest gain of 0.4% for the stock today. The analyst upgrade suggests confidence in the company's future performance and valuation potential, which typically provides positive momentum for a stock's intraday trading. 31-AUG-2026 06:22 AM ET